For In Vitro Diagnostic Use 

Teknova Active Viral Transport Medium (ATM) has not been reviewed by the FDA. 

Teknova ATM is intended for use in the transport of clinical specimens containing upper respiratory viruses from collection sites to testing sites for use with molecular or antigen diagnostic tests during the COVID-19 public health emergency. This medium is to be used by trained and qualified professionals. 

Teknova ATM is a room temperature–stable, non-propagating medium. Sample integrity is maintained for up to 72 hours after collection, when the sample is stored at 20–25°C (room temperature) or 2–8°C (refrigerated). 

ATM is manufactured in compliance with the recommendations of the US FDA Enforcement Policy (i.e., Alternate Approach or additional media type. Sec. IV B. 4.). The alternate approach is a modification of the CDC Formulation (CDC Protocol: SOP DSR-052-05). 

As set forth in Section IV.B of the FDA's COVID-19 Transport Media Policy, Teknova has completed the notification process and the Teknova ATM is on the FDA list of commercial manufacturers developing and distributing viral transport media (VTM) under the policy. 


** For transport of specimens only ** 

** Not to be taken internally ** 

Storage: 2025°C. 

Expiration: 1 year after manufacture date.


  • Bovine Serum Albumin
  • Phenol Red
  • Sucrose
  • L-Glutamic Acid
  • HEPES, Free Acid
  • Gelatin 
  • Gentamicin 
  • Amphotericin B (Fungizone)
Prepared in Hanks Balanced Salt Solution
Teknova Active Viral Transport Medium, 3 mL, 100 tubes per pack
Fill Volume: 3 mL
Packaging Size: 100


Teknova Active Viral Transport Medium, 3 mL, 100 tubes per pack
More Information
SKU AT2020
Additive Selection No
Antibiotics Selection Gentamicin, Amphotericin B (fungizone)
LB Media Type No
Organism No
pH Range 7.40 ± 0.04
Instructions for Use

Download IFU

Shipping Conditions Room Temperature
Storage Conditions 20–25°C